{"nct_id":"NCT02647086","title":"Open Label, Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD)","status":"COMPLETED","status_verified_date":"2016-08","start_date":"2015-12","start_date_type":null,"primary_completion_date":"2016-07","primary_completion_date_type":"ACTUAL","completion_date":"2016-07","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["REGN"]}